ACE2 and cancer: Multiple studies report the poor clinical outcome of COVID-19 patients frequently observed among the elderly population and in the presence of comorbidities which include angiotensin-converting enzyme-2 polymorphism, cancer, cancer chemotherapy, chronic kidney disease, thyroid disorder, diabetes, CVD, hypertension, oxidative stress, vitamin deficiency, or hematological disorders [255,256,257,258].